Data / Drug companies / Alivira Animal Health Limited
Alivira Animal Health Limited: 30 products in the FDA NDC directory, labeler code 86055
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Alivira Animal Health Limited (labeler code 86055) lists 30 products in the FDA National Drug Code Directory. By type: 30 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on May 24, 2023.
The request: Watch Alivira Animal Health Limited (FDA labeler code 86055): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 86055
- Products in commercial distribution
- 30
- Packages
- 52
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- August 17, 2015
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 30 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 30 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 30 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Lufenuron | 86055-0029 | Powder | Bulk ingredients | May 24, 2023 |
| Levamisole hydrochloride | 86055-0028 | Powder | Bulk ingredients | December 31, 2022 |
| Tildipirosin | 86055-0026 | Powder | Bulk ingredients | November 16, 2022 |
| Flubendazole | 86055-0027 | Powder | Bulk ingredients | November 15, 2022 |
| Zilpaterol hydrochloride | 86055-0025 | Powder | Bulk ingredients | November 10, 2021 |
| Imidocarb dipropionate | 86055-0023 | Powder | Bulk ingredients | April 8, 2021 |
| Nitroxynil | 86055-0024 | Powder | Bulk ingredients | April 1, 2021 |
| Buparvaquone | 86055-0022 | Powder | Bulk ingredients | December 16, 2020 |
| Ractopamine hydrochloride | 86055-0021 | Powder | Bulk ingredients | October 16, 2020 |
| Xylazine hydrochloride | 86055-0020 | Powder | Bulk ingredients | July 21, 2020 |
| Xylazine hydrochloride | 86055-0020 | Powder | Bulk ingredients | July 21, 2020 |
| Mavacoxib | 86055-0019 | Powder | Bulk ingredients | March 16, 2020 |
| Febantel | 86055-0018 | Powder | Bulk ingredients | November 23, 2019 |
| Deracoxib | 86055-0017 | Powder | Bulk ingredients | November 23, 2019 |
| Nitroscanate | 86055-0016 | Powder | Bulk ingredients | November 23, 2019 |
| Robenacoxib | 86055-0015 | Powder | Bulk ingredients | June 26, 2019 |
| Closantel sodium | 86055-0014 | Powder | Bulk ingredients | June 25, 2019 |
| Diclazuril | 86055-0013 | Powder | Bulk ingredients | December 27, 2018 |
| Firocoxib | 86055-0012 | Powder | Bulk ingredients | June 26, 2018 |
| Oxfendazole | 86055-0011 | Powder | Bulk ingredients | June 23, 2018 |
| Ponazuril | 86055-0009 | Powder | Bulk ingredients | January 1, 2018 |
| Triclabendazole | 86055-0006 | Powder | Bulk ingredients | January 15, 2017 |
| Clorsulon | 86055-0005 | Powder | Bulk ingredients | January 15, 2017 |
| Toltrazuril | 86055-0010 | Powder | Bulk ingredients | January 1, 2017 |
| Albendazole | 86055-0004 | Powder | Bulk ingredients | January 25, 2016 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.